Managing Intellectual Property analyzed ANDA litigation data from Docket Navigator, which highlights the District of New Jersey and the District of Delaware as the top venues for ANDA litigation in 2020. It is not surprising these are the top venues, as the majority of generics companies in the United States are based or incorporated in Delaware or New Jersey. Managing Intellectual Property interviewed Finnegan partner Laura Masurovsky for her thoughts on the data and the future of the ANDA litigation landscape.

Laura said, “My suspicion is that because of the expertise of these courts in pharma patent cases, there will be just as many if not more cases filed in Delaware and New Jersey in the future.”

Read “How 2020 ANDA Litigation Played Out – and What to Expect for 2021”